Xenofon B.
- Country
- Germany
- Department
- Rheumazentrum Ruhrgebiet Herne
Research Overview
- Evaluation of ERAP Inhibition in Patients with Axial Spondyloarthritis: The EAST-1 Clinical Trial
- An Open-Label Extension Study to Evaluate Long Term Safety and Efficacy of Tildrakizumab in Patients with Psoriatic Arthritis.
- A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
Data & Insights
Has run more than one trial at 168 of 312 partner sites.
Specializations
Psoriatic Arthritis Research
This investigator specializes in evaluating novel therapeutic approaches for psoriatic arthritis (PsA), with particular emphasis on biological disease-modifying treatments. Their research encompasses studies of various therapeutic agents including tildrakizumab, sonelokimab, risankizumab, and bimekizumab.
- Treatment-experienced patient populations
- Biologic-naïve patient groups
- Long-term therapeutic outcomes
Their work includes assessment of treatment responses in both anti-TNF experienced and naïve patients, focusing on clinical efficacy measures and safety profiles.
Axial Spondyloarthritis Studies
The investigator conducts comprehensive research in axial spondyloarthritis (axSpA), exploring innovative treatment approaches through various therapeutic agents including filgotinib and IL-23 inhibitors.
- Early disease intervention strategies
- Imaging-based assessment methods
- Comparative treatment effectiveness
Their research extends to advanced imaging techniques and long-term therapeutic outcomes in axSpA patient populations.
Treatment Innovation
The investigator's work centers on evaluating novel biological therapies and their application in rheumatic conditions. Their research encompasses both established and emerging therapeutic approaches.
- Biological DMARD efficacy
- Safety profile assessment
- Treatment response markers
Focus areas include comparative effectiveness research and the evaluation of therapeutic responses across different patient subgroups.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
